Want to ask George W. Bush a question about his stent…or anything else? Click here!
Six months ago, former President Bush received an angioplasty and stent. The stent was recommended by Bush’s doctors to open a blockage in one of his coronary arteries, found during his annual physical exam. EKG changes were seen on his stress test, a CT angiogram was performed and a blockage seen. He was rushed off to Texas Health Presbyterian Hospital in Dallas where Dr. Tony Das performed a percutaneous coronary intervention (PCI, a.k.a. angioplasty). A single stent was inserted in the newly opened vessel. Continue reading
Former President George W. Bush received an angioplasty and stent this morning at Texas Health Presbyterian Hospital Dallas. The stent was recommended by Bush’s doctors to open a blockage in one of his coronary arteries, found yesterday during what was described by Bush spokesman Freddy Ford as his annual physical exam at the Cooper Clinic in Dallas. Continue reading
Filed under Angiograms, Appropriate Use Criteria (AUC), Cardiac CT, Celebrity Patients, COURAGE, Drug-Eluting Stents, FFR, Imaging, Media Coverage, Non-Invasive Testing, Optimal Medical Therapy, Stent
Yesterday’s edition of USA Today carried an article by Peter Eisler titled, “Six common surgeries often done unnecessarily” — and, you guessed it, angioplasty and stents were at the top of the list of “six common surgeries that carry significant risks of being done without medical necessity, according to federal data and independent studies.”
I was a bit taken aback because I was not aware of any new study, federal or independent, that concluded stents were being vastly over-used. And it turns out that there wasn’t one. Continue reading
Today the editors of the HEART Group Journals, comprising the Journal of the American College of Cardiology and other participating cardiovascular publications, issued a “Statement on Matching Language to the Type of Evidence Used in Describing Outcomes Data.”
Although the title of the article may be a bit yawn-inducing, the editors deserve a kudo or two for attempting to clarify reporting on medical issues. Continue reading
Is this stent necessary? Is this angioplasty inappropriate? Is this cardiologist uncertain if the procedure will help? Ever since the Appropriate Use Criteria for Coronary Revascularization were published, the three category labels of “appropriate,” “uncertain,” and “inappropriate” have confused the profession, press and population at large. The issue of definitions had still not been addressed in the most recent update of the AUC.
So (drumroll, please) yesterday, new categories were approved by the ACC Appropriateness Use Criteria Working Group. The new terminology will be “Appropriate,” “May Be Appropriate”(which replaces “Uncertain”), and “Rarely Appropriate” (which replaces “Inappropriate”). Continue reading
Artist illustration of the iFR “Wave Free Period”
As previously reported on Angioplasty.Org, a new method for the functional measurement of intracoronary pressures and the severity of blockages has been developed by researchers at Imperial College in London. One of the main advantages of this new method, called Instant Wave-Free Ratio™ (iFR), is that, unlike standard fractional flow reserve (FFR), it does not require injection of a vasodilator drug, such as adenosine, to induce stress on the heart. The result is that the procedure is more comfortable for the patient and potentially useable in clinical scenarios where vasodilation is not feasible, such as acute coronary syndromes, infarctions, unstable patients, patients with breathing problems; it may also be somewhat quicker, easier to use, and more cost-effective. Continue reading
Earlier today, the opening day of EuroPCR, Dr. Bernard De Bruyne presented preliminary results from the FAME II trial which tested the diagnostic power of Fractional Flow Reserve to guide PCI (stenting) of the coronary arteries. I wrote about FAME II back in January, when enrollment in the trial was halted for ethical reasons because the results of the ongoing FAME II trial were showing that the outcomes for stents in patients with stable angina were clearly superior to those in patients who were being treated with medications (a.k.a. Optimal Medical Therapy or OMT) alone. An independent Data Safety Monitoring Board advised that continuing the randomization would not change the findings and so, it was unethical to withhold the option of stents from this patient population. Continue reading